| European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment V Roessner, KJ Plessen, A Rothenberger, AG Ludolph, R Rizzo, L Skov, ... European child & adolescent psychiatry 20, 173-196, 2011 | 540 | 2011 |
| Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment N Müller, D Krause, S Dehning, R Musil, R Schennach-Wolff, ... Schizophrenia research 121 (1-3), 118-124, 2010 | 300 | 2010 |
| Weight gain and antipsychotics: a drug safety review R Musil, M Obermeier, P Russ, M Hamerle Expert opinion on drug safety 14 (1), 73-96, 2015 | 200 | 2015 |
| Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis BB Barton, F Segger, K Fischer, M Obermeier, R Musil Expert opinion on drug safety 19 (3), 295-314, 2020 | 162 | 2020 |
| Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an … G Arteaga-Henríquez, MS Simon, B Burger, E Weidinger, A Wijkhuijs, ... Frontiers in psychiatry 10, 458, 2019 | 139 | 2019 |
| Review and consensus on pharmacogenomic testing in psychiatry CA Bousman, SA Bengesser, KJ Aitchison, AT Amare, H Aschauer, ... Pharmacopsychiatry 54 (01), 5-17, 2021 | 132 | 2021 |
| Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression—no influence of celecoxib treatment R Musil, MJ Schwarz, M Riedel, S Dehning, A Cerovecki, I Spellmann, ... Journal of affective disorders 134 (1-3), 217-225, 2011 | 132 | 2011 |
| Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations A Cerovecki, R Musil, A Klimke, F Seemüller, E Haen, R Schennach, ... CNS drugs 27, 545-572, 2013 | 111 | 2013 |
| Outcomes of 1014 naturalistically treated inpatients with major depressive episode F Seemüller, M Riedel, M Obermeier, M Bauer, M Adli, K Kronmüller, ... European Neuropsychopharmacology 20 (5), 346-355, 2010 | 99 | 2010 |
| The vicious circle of social exclusion and psychopathology: A systematic review of experimental ostracism research in psychiatric disorders MA Reinhard, J Dewald-Kaufmann, T Wuestenberg, R Musil, BB Barton, ... European Archives of Psychiatry and Clinical Neuroscience 270 (5), 521-532, 2020 | 97 | 2020 |
| Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms M Riedel, N Müller, M Strassnig, I Spellmann, RR Engel, R Musil, ... European archives of psychiatry and clinical neuroscience 255, 432-437, 2005 | 79 | 2005 |
| Treatment response in first-episode schizophrenia R Schennach, M Riedel, R Musil, HJ Möller Clinical Psychopharmacology and Neuroscience 10 (2), 78, 2012 | 71 | 2012 |
| Neurocognition and its influencing factors in the treatment of schizophrenia—effects of aripiprazole, olanzapine, quetiapine and risperidone M Riedel, R Schennach‐Wolff, R Musil, S Dehning, A Cerovecki, ... Human Psychopharmacology: Clinical and Experimental 25 (2), 116-125, 2010 | 70 | 2010 |
| Efficacy of acupuncture for primary insomnia: a randomized controlled clinical trial J Guo, LP Wang, CZ Liu, J Zhang, GL Wang, JH Yi, JL Cheng, R Musil Deutsche Zeitschrift für Akupunktur 57, 31-32, 2014 | 65 | 2014 |
| Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia M Riedel, N Müller, I Spellmann, RR Engel, R Musil, R Valdevit, ... European archives of psychiatry and clinical neuroscience 257, 402-412, 2007 | 64 | 2007 |
| Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients I Spellmann, D Rujescu, R Musil, A Mayr, I Giegling, J Genius, P Zill, ... Journal of psychiatric research 45 (2), 234-241, 2011 | 63 | 2011 |
| Effect of aripiprazole on cognition in the treatment of patients with schizophrenia M Riedel, I Spellmann, R Schennach-Wolff, R Musil, S Dehning, ... Pharmacopsychiatry 43 (02), 50-57, 2010 | 57 | 2010 |
| SNAP-25 gene polymorphisms and weight gain in schizophrenic patients R Musil, I Spellmann, M Riedel, S Dehning, A Douhet, K Maino, P Zill, ... Journal of psychiatric research 42 (12), 963-970, 2008 | 57 | 2008 |
| A genetic variant of HTR2C may play a role in the manifestation of Tourette syndrome S Dehning, N Müller, J Matz, A Bender, I Kerle, J Benninghoff, R Musil, ... Psychiatric genetics 20 (1), 35-38, 2010 | 55 | 2010 |
| Functional outcomes in schizophrenia: employment status as a metric of treatment outcome R Schennach, R Musil, HJ Möller, M Riedel Current psychiatry reports 14, 229-236, 2012 | 54 | 2012 |
